[HTML][HTML] Beta-lapachone, a modulator of NAD metabolism, prevents health declines in aged mice
… βL-fed mice did not alter their food-intake or locomotor activity but did increase their energy
expenditure as measured by oxygen consumption and heat generation … (2012) Beta-Lapachone,
a Modulator of NAD Metabolism, Prevents Health Declines in Aged Mice …
expenditure as measured by oxygen consumption and heat generation … (2012) Beta-Lapachone,
a Modulator of NAD Metabolism, Prevents Health Declines in Aged Mice …
Preclinical and clinical studies of lapachol and beta-lapachone
ER Almeida - The Open Natural Products Journal, 2009 - benthamopen.com
… Res., 1999, 30(1), 73-83 [15] Woo, HJ; Park, KY; Rhu, CH Beta-lapachone, a quinone iso- lated
from Tabebuia avellanedae, induces apoptosis in HepG2 he- patoma cell line through induction
of Bax and activation of caspase. J. Med. Food, 2006, 9(2), 161-168 [16] Manna, SK …
from Tabebuia avellanedae, induces apoptosis in HepG2 he- patoma cell line through induction
of Bax and activation of caspase. J. Med. Food, 2006, 9(2), 161-168 [16] Manna, SK …
Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
Z Jiang, DG Reddy - US Patent 7,074,824, 2006 - Google Patents
… Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof,
and methods of using same. Download PDF Info … Emulsions of Beta-Lapachone in a
pharmaceutically acceptable fat emulsion vehicle are also provided …
and methods of using same. Download PDF Info … Emulsions of Beta-Lapachone in a
pharmaceutically acceptable fat emulsion vehicle are also provided …
Toxicological assessment of beta‐lapachone on organs from pregnant and non‐pregnant rats
ER de Almeida, FRS Lucena… - … Journal Devoted to …, 2009 - Wiley Online Library
… Page 2. TOXICOLOGICAL ASSESSMENT OF BETA-LAPACHONE 1277 … As observed in Tables
1 and 2, the beta-lap at the three doses (40, 80, and 160 mg/kg) administered on days 7–12 cage,
with a light/dark period of 12 h (6:00 am to 6:00 pm) and food and water ad libitum …
1 and 2, the beta-lap at the three doses (40, 80, and 160 mg/kg) administered on days 7–12 cage,
with a light/dark period of 12 h (6:00 am to 6:00 pm) and food and water ad libitum …
Beta-lapachone suppresses non-small cell lung cancer proliferation through the regulation of specificity protein 1
YJ Jeon, W Bang, YH Choi, JH Shim… - Biological and …, 2015 - jstage.jst.go.jp
… J. Med. Food, 13, 481–488 (2010). 8) Ferreira SB, Salomao K, de Carvalho da Silva F, Pinto AV,
Kaiser CR, Pinto AC, Ferreira VF, de Castro SL. Synthesis and anti-Trypanosoma cruzi activity
of beta-lapachone analogues. Eur. J. Med. Chem., 46, 3071–3077 (2011) …
Kaiser CR, Pinto AC, Ferreira VF, de Castro SL. Synthesis and anti-Trypanosoma cruzi activity
of beta-lapachone analogues. Eur. J. Med. Chem., 46, 3071–3077 (2011) …
Beta-lapachone prevents diet-induced obesity by increasing energy expenditure and stimulating the browning of white adipose tissue via down-regulation of miR-382 …
WH Choi, J Ahn, CH Jung, YJ Jang, TY Ha - Diabetes, 2016 - Am Diabetes Assoc
Page 1. Beta-lapachone prevents diet-induced obesity by increasing energy expenditure and …
Won Hee Choi1,2, Jiyun Ahn1,2, Chang Hwa Jung1.2, Young Jin Jang1, Tae Youl Ha1,2
1Research Group of Nutrition and Metabolic System, Korea Food Research Institute …
Won Hee Choi1,2, Jiyun Ahn1,2, Chang Hwa Jung1.2, Young Jin Jang1, Tae Youl Ha1,2
1Research Group of Nutrition and Metabolic System, Korea Food Research Institute …
Characterization of β-lapachone and methylated β-cyclodextrin solid-state systems
MSS Cunha-Filho, B Dacunha-Marinho… - Aaps …, 2007 - Springer
… In vitro dissolution studies were performed following Food and Drug Administration (FDA)
specifications for poor sol- uble drugs using a United States Pharmacopeia (USP) dis- solution
apparatus 2 (paddle) (Turu Grau DT-6, Barcelona, Spain) at 75 rpm and 37-C (±0.5-C).28 …
specifications for poor sol- uble drugs using a United States Pharmacopeia (USP) dis- solution
apparatus 2 (paddle) (Turu Grau DT-6, Barcelona, Spain) at 75 rpm and 37-C (±0.5-C).28 …
[HTML][HTML] Impact of micellar vehicles on in situ intestinal absorption properties of beta-lapachone in rats
SB Jang, D Kim, SY Kim, C Park… - The Korean Journal …, 2013 - synapse.koreamed.org
… b-lap, beta-lapachone … H, Yamashita S. Effect of administration site in the gastrointestinal tracton
bioavailability of poorly absorbed drugstaken after a meal … P, Knutson L, Ohgren C, Forssén S,
Lennernäs H, Abrahamsson B. Improved understanding of the effect of food on drug …
bioavailability of poorly absorbed drugstaken after a meal … P, Knutson L, Ohgren C, Forssén S,
Lennernäs H, Abrahamsson B. Improved understanding of the effect of food on drug …
[PDF][PDF] The chemotherapeutic effects of lapacho tree extract: β-lapachone
HN Kung, KS Lu, YP Chau - Chemotherapy, 2014 - researchgate.net
… In recent, a Food and Drug Administration (FDA)- approved non-steroidal anti-inflammation drug
(NSAID), sulindac [35], is demonstrated by … Seigle-Murandi F, Simeon de Buochberg M (1994)
Comparison of antibacterial and antifungal activities of lapachol and beta-lapachone …
(NSAID), sulindac [35], is demonstrated by … Seigle-Murandi F, Simeon de Buochberg M (1994)
Comparison of antibacterial and antifungal activities of lapachol and beta-lapachone …
β-Lapachone-induced reactive oxygen species (ROS) generation mediates autophagic cell death in glioma U87 MG cells
EJ Park, KS Choi, TK Kwon - Chemico-biological interactions, 2011 - Elsevier
… J. Med. Chem., 27 (1984), pp. 990-994. [6] DA Boothman, S. Greer, AB PardeePotentiation of
halogenated pyrimidine radiosensitizers in human carcinoma cells by beta-lapachone
(3,4-dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran-5,6-dione), a novel DNA repair inhibitor …
halogenated pyrimidine radiosensitizers in human carcinoma cells by beta-lapachone
(3,4-dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran-5,6-dione), a novel DNA repair inhibitor …
Related searches
- derivatives or analogs beta lapachone
- health declines beta lapachone
- non pregnant rats beta lapachone
- regulation of specificity protein beta lapachone
- anti-cancer therapies beta lapachone
- enhancement of radiation effect beta lapachone
- human retinoblastoma y79 cells beta lapachone
- activation of map kinases beta lapachone
- preclinical and clinical studies beta lapachone
- white adipose tissue beta lapachone
- pharmaceutical compositions beta lapachone
- cell lung cancer proliferation beta lapachone
- aged mice beta lapachone
- toxicological assessment beta lapachone
- underlying mechanism beta lapachone
- phospho akt beta lapachone